Susquehanna International Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-28,700
| Closed | -$4.59K | – | 13569 |
|
|
2023
Q1 | $4.59K | Sell |
28,700
-11,500
| -29% | -$5.11K | ﹤0.01% | 12313 |
|
|
2022
Q4 | $22.5K | Sell |
40,200
-40,200
| -50% | -$34.2K | ﹤0.01% | 11726 |
|
|
2022
Q3 | $96K | Sell |
80,400
-4,700
| -6% | -$5.07K | ﹤0.01% | 11742 |
|
|
2022
Q2 | $54K | Buy |
85,100
+4,200
| +5% | +$3.22K | ﹤0.01% | 11940 |
|
|
2022
Q1 | $92K | Sell |
80,900
-132,400
| -62% | -$158K | ﹤0.01% | 11972 |
|
|
2021
Q4 | $480K | Sell |
213,300
-38,900
| -15% | -$97.6K | ﹤0.01% | 9322 |
|
|
2021
Q3 | $863K | Buy |
252,200
+11,400
| +5% | +$35.1K | ﹤0.01% | 7954 |
|
|
2021
Q2 | $720K | Sell |
240,800
-54,200
| -18% | -$171K | ﹤0.01% | 8674 |
|
|
2021
Q1 | $953K | Buy |
295,000
+211,500
| +253% | +$706K | ﹤0.01% | 7867 |
|
|
2020
Q4 | $177K | Buy |
+83,500
| New | +$138K | ﹤0.01% | 10138 |
|
|
2018
Q4 | – | Sell |
-10,800
| Closed | -$29K | – | 10232 |
|
|
2018
Q3 | $29K | Sell |
10,800
-24,300
| -69% | -$50.3K | ﹤0.01% | 8952 |
|
|
2018
Q2 | $67K | Buy |
35,100
+1,000
| +3% | +$2.02K | ﹤0.01% | 9189 |
|
|
2018
Q1 | $72K | Buy |
34,100
+21,700
| +175% | +$46.5K | ﹤0.01% | 8836 |
|
|
2017
Q4 | $25K | Buy |
+12,400
| New | +$25.7K | ﹤0.01% | 9046 |
|
|
2017
Q3 | – | Sell |
-43,300
| Closed | -$68K | – | 9843 |
|
|
2017
Q2 | $68K | Buy |
43,300
+21,400
| +98% | +$41.3K | ﹤0.01% | 8824 |
|
|
2017
Q1 | $71K | Sell |
21,900
-83,100
| -79% | -$204K | ﹤0.01% | 8505 |
|
|
2016
Q4 | $142K | Buy |
105,000
+93,700
| +829% | +$122K | ﹤0.01% | 8886 |
|
|
2016
Q3 | $18K | Buy |
+11,300
| New | +$17.4K | ﹤0.01% | 8256 |
|
|
2016
Q1 | – | Sell |
-122,800
| Closed | -$964K | – | 9849 |
|
|
2015
Q4 | $964K | Sell |
122,800
-28,200
| -19% | -$243K | ﹤0.01% | 5474 |
|
|
2015
Q3 | $1.28M | Sell |
151,000
-40,300
| -21% | -$372K | ﹤0.01% | 5177 |
|
|
2015
Q2 | $2.1M | Buy |
191,300
+1,800
| +0.9% | +$23.1K | ﹤0.01% | 4621 |
|
|
2015
Q1 | $2.65M | Sell |
189,500
-113,900
| -38% | -$1.74M | ﹤0.01% | 3767 |
|
|
2014
Q4 | $5.12M | Buy |
303,400
+26,200
| +9% | +$381K | ﹤0.01% | 2851 |
|
|
2014
Q3 | $3.72M | Sell |
277,200
-260,500
| -48% | -$3.1M | ﹤0.01% | 3497 |
|
|
2014
Q2 | $6.85M | Buy |
537,700
+335,900
| +166% | +$3.5M | ﹤0.01% | 2606 |
|
|
2014
Q1 | $2.4M | Sell |
201,800
-288,500
| -59% | -$3.87M | ﹤0.01% | 4032 |
|
|
2013
Q4 | $6.77M | Buy |
490,300
+275,200
| +128% | +$3.89M | ﹤0.01% | 2520 |
|
|
2013
Q3 | $3.75M | Sell |
215,100
-153,200
| -42% | -$2.93M | ﹤0.01% | 3129 |
|
|
2013
Q2 | $5.99M | Buy |
+368,300
| New | +$11.4M | ﹤0.01% | 2393 |
|
Other funds holding INFI
Susquehanna International Group's INFI Position: Q3 2023 in Review
Susquehanna International Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 11,008 shares — an estimated $2.32K sold.
Susquehanna International Group first reported a position in INFI in Q2 2013 and held it in 35 quarters. The position peaked at $7.53M in Q4 2013. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- Susquehanna International Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Susquehanna International Group sold 11,008 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $2.32K.
- Susquehanna International Group first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 35 quarters.
- Susquehanna International Group's Infinity Pharmaceuticals, Inc. position peaked at $7.53M in Q4 2013.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.